Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases.
Amber L SimpsonJacob J PeoplesJohn M CreasyGabor FichtingerNatalie GangaiKrishna Nand Keshava MurthyAndras LassoJinru ShiaMichael I D'AngelicaRichard Kinh Gian DoPublished in: Scientific data (2024)
The liver is a common site for the development of metastases in colorectal cancer. Treatment selection for patients with colorectal liver metastases (CRLM) is difficult; although hepatic resection will cure a minority of CRLM patients, recurrence is common. Reliable preoperative prediction of recurrence could therefore be a valuable tool for physicians in selecting the best candidates for hepatic resection in the treatment of CRLM. It has been hypothesized that evidence for recurrence could be found via quantitative image analysis on preoperative CT imaging of the future liver remnant before resection. To investigate this hypothesis, we have collected preoperative hepatic CT scans, clinicopathologic data, and recurrence/survival data, from a large, single-institution series of patients (n = 197) who underwent hepatic resection of CRLM. For each patient, we also created segmentations of the liver, vessels, tumors, and future liver remnant. The largest of its kind, this dataset is a resource that may aid in the development of quantitative imaging biomarkers and machine learning models for the prediction of post-resection hepatic recurrence of CRLM.
Keyphrases
- patients undergoing
- liver metastases
- free survival
- end stage renal disease
- machine learning
- high resolution
- ejection fraction
- newly diagnosed
- electronic health record
- big data
- chronic kidney disease
- prognostic factors
- dual energy
- primary care
- contrast enhanced
- peritoneal dialysis
- image quality
- magnetic resonance imaging
- current status
- magnetic resonance
- mass spectrometry
- patient reported outcomes
- artificial intelligence
- fluorescence imaging
- pet ct